Stephen Miller - Publications

Northwestern University, Evanston, IL 
Molecular Neuroscience, Neurobiology of Disease, Neuroimmunology

167 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lee FT, Dangi A, Shah S, Burnette M, Yang YG, Kirk AD, Hering BJ, Miller SD, Luo X. Rejection of xenogeneic porcine islets in humanized mice is characterized by graft-infiltrating Th17 cells and activated B cells. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 31883299 DOI: 10.1111/ajt.15763  0.32
2019 DeBerge MP, Yu S, Dehn S, Ifergan I, Yeap XY, Filipp M, Becker A, Luo X, Miller SD, Thorp EB. Monocytes Prime Autoreactive T cells After Myocardial Infarction. American Journal of Physiology. Heart and Circulatory Physiology. PMID 31809213 DOI: 10.1152/ajpheart.00595.2019  0.32
2019 Saito E, Kuo R, Kramer KR, Gohel N, Giles DA, Moore BB, Miller SD, Shea LD. Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease. Biomaterials. 222: 119432. PMID 31480002 DOI: 10.1016/j.biomaterials.2019.119432  0.56
2019 Singh A, Ramachandran S, Graham ML, Daneshmandi S, Heller D, Suarez-Pinzon WL, Balamurugan AN, Ansite JD, Wilhelm JJ, Yang A, Zhang Y, Palani NP, Abrahante JE, Burlak C, Miller SD, et al. Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes. Nature Communications. 10: 3495. PMID 31375697 DOI: 10.1038/s41467-019-11338-y  0.32
2019 Saito E, Kuo R, Pearson RM, Gohel N, Cheung B, King NJC, Miller SD, Shea LD. Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30822435 DOI: 10.1016/j.jconrel.2019.02.025  0.56
2019 Chen Y, Podojil JR, Kunjamma RB, Jones J, Weiner M, Lin W, Miller SD, Popko B. Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis. Brain : a Journal of Neurology. PMID 30657878 DOI: 10.1093/brain/awy322  0.6
2018 Pearson RM, Podojil JR, Shea LD, King NJ, Miller SD, Getts DR. OVERCOMING CHALLENGES IN TREATING AUTOIMMUNTITY: DEVELOPMENT OF tolerogenic immune-modifying nanoparticles. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30352312 DOI: 10.1016/j.nano.2018.10.001  0.72
2018 Smarr CB, Miller SD. The Use of Biodegradable Nanoparticles for Tolerogenic Therapy of Allergic Inflammation. Methods in Molecular Biology (Clifton, N.J.). 1799: 353-358. PMID 29956163 DOI: 10.1007/978-1-4939-7896-0_25  1
2018 Podojil JR, Chiang MY, Ifergan I, Copeland R, Liu LN, Maloveste S, Langermann S, Liebenson D, Balabanov R, Chi H, Chen L, Vignali DAA, Miller SD. B7-H4 Modulates Regulatory CD4 T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex. Journal of Immunology (Baltimore, Md. : 1950). PMID 29898965 DOI: 10.4049/jimmunol.1700811  0.6
2018 Xu D, Robinson AP, Ishii T, Duncan DS, Alden TD, Goings GE, Ifergan I, Podojil JR, Penaloza-MacMaster P, Kearney JA, Swanson GT, Miller SD, Koh S. Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy. The Journal of Experimental Medicine. PMID 29487082 DOI: 10.1084/jem.20171285  0.92
2018 Glaser AP, Fantini D, Wang Y, Yu Y, Rimar KJ, Podojil JR, Miller SD, Meeks JJ. APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response. Oncotarget. 9: 4537-4548. PMID 29435122 DOI: 10.18632/oncotarget.23344  0.6
2018 Hecht I, Toporik A, Podojil JR, Vaknin I, Cojocaru G, Oren A, Aizman E, Liang SC, Leung L, Dicken Y, Novik A, Marbach-Bar N, Elmesmari A, Tange C, Gilmour A, ... ... Miller SD, et al. ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses. Journal of Immunology (Baltimore, Md. : 1950). PMID 29431694 DOI: 10.4049/jimmunol.1700325  0.6
2018 Podojil JR, Hecht I, Chiang MY, Vaknin I, Barbiro I, Novik A, Neria E, Rotman G, Miller SD. ILDR2-Fc Is a Novel Regulator of Immune Homeostasis and Inducer of Antigen-Specific Immune Tolerance. Journal of Immunology (Baltimore, Md. : 1950). PMID 29431690 DOI: 10.4049/jimmunol.1700326  0.6
2017 Prasad S, Neef T, Xu D, Podojil JR, Getts DR, Shea LD, Miller SD. Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells. Journal of Autoimmunity. PMID 29258717 DOI: 10.1016/j.jaut.2017.12.010  0.72
2017 Casey LM, Pearson RM, Hughes K, Liu J, Rose J, North MG, Wang L, Mei L, Miller SD, Shea LD. Conjugation of transforming growth factor beta to antigen-loaded poly(lactide-co-glycolide) nanoparticles enhances efficiency of antigen-specific tolerance. Bioconjugate Chemistry. PMID 29148731 DOI: 10.1021/acs.bioconjchem.7b00624  0.56
2017 Ifergan I, Davidson TS, Kebir H, Xu D, Palacios-Macapagal D, Cann J, Rodgers JM, Hunter ZN, Pittet CL, Beddow S, Jones CA, Prat A, Sleeman MA, Miller SD. Targeting the GM-CSF receptor for the treatment of CNS autoimmunity. Journal of Autoimmunity. PMID 28641926 DOI: 10.1016/j.jaut.2017.06.005  0.96
2017 Pearson RM, Casey LM, Hughes KR, Wang LZ, North MG, Getts DR, Miller SD, Shea LD. Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28479234 DOI: 10.1016/j.ymthe.2017.04.015  0.72
2017 Pearson RM, Casey LM, Hughes KR, Miller SD, Shea LD. In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance. Advanced Drug Delivery Reviews. PMID 28414079 DOI: 10.1016/j.addr.2017.04.005  0.56
2017 Kuo R, Saito E, Miller SD, Shea LD. Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28408181 DOI: 10.1016/j.ymthe.2017.03.032  0.56
2017 Podojil JR, Miller SD. Potential targeting of B7-H4 for the treatment of cancer. Immunological Reviews. 276: 40-51. PMID 28258701 DOI: 10.1111/imr.12530  0.6
2016 Kang HK, Wang S, Dangi A, Zhang X, Singh A, Zhang L, Rosati JM, Suarez-Pinzon W, Deng X, Chen X, Thorp EB, Hering BJ, Miller SD, Luo X. Differential role of B cells and IL-17 versus IFN-γ during early and late rejection of pig islet xenografts in mice. Transplantation. PMID 27893617 DOI: 10.1097/TP.0000000000001489  0.32
2016 McCarthy DP, Yap JW, Harp CT, Song WK, Chen J, Pearson RM, Miller SD, Shea LD. An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 27720992 DOI: 10.1016/j.nano.2016.09.007  0.76
2016 Getts DR, Shea LD, Miller SD, King NJ. Harnessing Nanoparticles for Immune Modulation: (Trends in Immunology 36, 419-427; July 2016). Trends in Immunology. PMID 27614797 DOI: 10.1016/  0.72
2016 Smarr CB, Yap WT, Neef TP, Pearson RM, Hunter ZN, Ifergan I, Getts DR, Bryce PJ, Shea LD, Miller SD. Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization. Proceedings of the National Academy of Sciences of the United States of America. PMID 27091976 DOI: 10.1073/pnas.1505782113  0.96
2016 Luo X, Miller SD, Shea LD. Immune Tolerance for Autoimmune Disease and Cell Transplantation. Annual Review of Biomedical Engineering. PMID 26928211 DOI: 10.1146/annurev-bioeng-110315-020137  0.96
2016 Ifergan I, Chen S, Zhang B, Miller SD. Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). PMID 26783338 DOI: 10.4049/jimmunol.1501965  0.96
2016 Winger RC, Harp CT, Chiang MY, Sullivan DP, Watson RL, Weber EW, Podojil JR, Miller SD, Muller WA. Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease. Journal of Immunology (Baltimore, Md. : 1950). PMID 26773145 DOI: 10.4049/jimmunol.1501634  0.32
2015 Traka M, Podojil JR, McCarthy DP, Miller SD, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nature Neuroscience. PMID 26656646 DOI: 10.1038/nn.4193  0.76
2015 Hussien Y, Podojil JR, Robinson AP, Lee AS, Miller SD, Popko B. ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 15921-33. PMID 26631473 DOI: 10.1523/JNEUROSCI.0693-15.2015  0.64
2015 Robinson AP, Rodgers JM, Goings GE, Miller SD. Characterizing oligodendroglial populations in development and disease using flow cytometry. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 47: 51-2. PMID 26531467 DOI: 10.1016/j.ijdevneu.2015.04.145  0.96
2015 Hlavaty KA, McCarthy DP, Saito E, Yap WT, Miller SD, Shea LD. Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation. Biomaterials. 76: 1-10. PMID 26513216 DOI: 10.1016/j.biomaterials.2015.10.041  0.96
2015 James RE, Hillis J, Adorján I, Gration B, Mundim MV, Iqbal AJ, Majumdar MM, Yates RL, Richards MM, Goings GE, DeLuca GC, Greaves DR, Miller SD, Szele FG. Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis. Glia. PMID 26337870 DOI: 10.1002/glia.22906  0.44
2015 Lawson BR, Gonzalez-Quintial R, Eleftheriadis T, Farrar MA, Miller SD, Sauer K, McGavern DB, Kono DH, Baccala R, Theofilopoulos AN. Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation. Clinical Immunology (Orlando, Fla.). 161: 260-269. PMID 26319414 DOI: 10.1016/j.clim.2015.08.007  0.96
2015 Chastain EM, Getts DR, Miller SD. Deficient Natural Killer Dendritic Cell Responses Underlay the Induction of Theiler's Virus-Induced Autoimmunity. Mbio. 6: e01175. PMID 26242630 DOI: 10.1128/mBio.01175-15  0.96
2015 Getts DR, Shea LD, Miller SD, King NJ. Harnessing nanoparticles for immune modulation. Trends in Immunology. 36: 419-27. PMID 26088391 DOI: 10.1016/  0.96
2015 Banisadr G, Podojil JR, Miller SD, Miller RJ. Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 25997895 DOI: 10.1007/s11481-015-9616-y  0.96
2015 Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, ... ... Miller SD, et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature. 522: 216-20. PMID 25896324 DOI: 10.1038/nature14335  0.96
2015 McCarthy DP, Bryant J, Galvin JP, Miller SD, Luo X. Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 15: 1475-83. PMID 25807873 DOI: 10.1111/ajt.13237  0.96
2015 Hlavaty KA, Luo X, Shea LD, Miller SD. Cellular and molecular targeting for nanotherapeutics in transplantation tolerance. Clinical Immunology (Orlando, Fla.). PMID 25805659 DOI: 10.1016/j.clim.2015.03.013  0.96
2015 Way SW, Podojil JR, Clayton BL, Zaremba A, Collins TL, Kunjamma RB, Robinson AP, Brugarolas P, Miller RH, Miller SD, Popko B. Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic. Nature Communications. 6: 6532. PMID 25766071 DOI: 10.1038/ncomms7532  0.96
2015 Rodgers JM, Robinson AP, Rosler ES, Lariosa-Willingham K, Persons RE, Dugas JC, Miller SD. IL-17A activates ERK1/2 and enhances differentiation of oligodendrocyte progenitor cells. Glia. 63: 768-79. PMID 25557204 DOI: 10.1002/glia.22783  0.96
2015 Wang S, Zhang X, Zhang L, Bryant J, Kheradmand T, Hering BJ, Miller SD, Luo X. Preemptive Tolerogenic Delivery of Donor Antigens for Permanent Allogeneic Islet Graft Protection. Cell Transplantation. 24: 1155-65. PMID 24759564 DOI: 10.3727/096368914X681027  0.32
2015 Smarr CB, Getts DR, Miller SD. Therapeutic Immune Tolerance Approaches for the Treatment of Allergic Disease Translational Immunology: Mechanisms and Pharmacologic Approaches. 259-284. DOI: 10.1016/B978-0-12-801577-3.00011-3  0.96
2014 Goldner JS, Quimby D, Richards MH, Zakaryan A, Miller S, Dickson D, Chilson J. Relations of Parenting to Adolescent Externalizing and Internalizing Distress Moderated by Perception of Neighborhood Danger. Journal of Clinical Child and Adolescent Psychology : the Official Journal For the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 1-14. PMID 25425100 DOI: 10.1080/15374416.2014.958838  0.72
2014 Robinson AP, Rodgers JM, Goings GE, Miller SD. Characterization of oligodendroglial populations in mouse demyelinating disease using flow cytometry: clues for MS pathogenesis. Plos One. 9: e107649. PMID 25247590 DOI: 10.1371/journal.pone.0107649  0.96
2014 Sarraj B, Ye J, Akl AI, Chen G, Wang JJ, Zhang Z, Abadja F, Abecassis M, Miller SD, Kansas GS, Ansari MJ. Impaired selectin-dependent leukocyte recruitment induces T-cell exhaustion and prevents chronic allograft vasculopathy and rejection. Proceedings of the National Academy of Sciences of the United States of America. 111: 12145-50. PMID 25092331 DOI: 10.1073/pnas.1303676111  0.96
2014 Yap WT, Song WK, Chauhan N, Scalise PN, Agarwal R, Miller SD, Shea LD. Quantification of particle-conjugated or particle-encapsulated peptides on interfering reagent backgrounds. Biotechniques. 57: 39-44. PMID 25005692 DOI: 10.2144/000114190  0.96
2014 Klaren RE, Motl RW, Woods JA, Miller SD. Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis). Journal of Neuroimmunology. 274: 14-9. PMID 24999244 DOI: 10.1016/j.jneuroim.2014.06.014  0.96
2014 Blink SE, Caldis MW, Goings GE, Harp CT, Malissen B, Prinz I, Xu D, Miller SD. γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis. Cellular Immunology. 290: 39-51. PMID 24860937 DOI: 10.1016/j.cellimm.2014.04.013  0.96
2014 Flechner SM, Mulgoankar S, Melton LB, Waid TH, Agarwal A, Miller SD, Fokta F, Getts MT, Frederick TJ, Herrman JJ, Puisis JP, O'Toole L, Sung R, Shihab F, Wiseman AC, et al. First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 14: 1346-55. PMID 24751150 DOI: 10.1111/ajt.12698  0.96
2014 Terry RL, Miller SD. Molecular control of monocyte development. Cellular Immunology. 291: 16-21. PMID 24709055 DOI: 10.1016/j.cellimm.2014.02.008  0.96
2014 McCarthy DP, Hunter ZN, Chackerian B, Shea LD, Miller SD. Targeted immunomodulation using antigen-conjugated nanoparticles. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 6: 298-315. PMID 24616452 DOI: 10.1002/wnan.1263  0.96
2014 Hunter Z, McCarthy DP, Yap WT, Harp CT, Getts DR, Shea LD, Miller SD. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. Acs Nano. 8: 2148-60. PMID 24559284 DOI: 10.1021/nn405033r  0.96
2014 Robinson AP, Harp CT, Noronha A, Miller SD. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handbook of Clinical Neurology. 122: 173-89. PMID 24507518 DOI: 10.1016/B978-0-444-52001-2.00008-X  0.96
2014 Banisadr G, Schwartz SR, Podojil JR, Piccinini LA, Lanker S, Miller SD, Miller RJ. Integrin/Chemokine receptor interactions in the pathogenesis of experimental autoimmune encephalomyelitis. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 9: 438-45. PMID 24477403 DOI: 10.1007/s11481-014-9521-9  0.96
2014 Getts DR, Terry RL, Getts MT, Deffrasnes C, Müller M, van Vreden C, Ashhurst TM, Chami B, McCarthy D, Wu H, Ma J, Martin A, Shae LD, Witting P, Kansas GS, ... ... Miller SD, et al. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Science Translational Medicine. 6: 219ra7. PMID 24431111 DOI: 10.1126/scitranslmed.3007563  0.96
2013 Xu D, Miller SD, Koh S. Immune mechanisms in epileptogenesis. Frontiers in Cellular Neuroscience. 7: 195. PMID 24265605 DOI: 10.3389/fncel.2013.00195  0.96
2013 Getts DR, McCarthy DP, Miller SD. Exploiting apoptosis for therapeutic tolerance induction. Journal of Immunology (Baltimore, Md. : 1950). 191: 5341-6. PMID 24244028 DOI: 10.4049/jimmunol.1302070  0.96
2013 Eaton VL, Vasquez KO, Goings GE, Hunter ZN, Peterson JD, Miller SD. Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo. Journal of Neuroinflammation. 10: 138. PMID 24237884 DOI: 10.1186/1742-2094-10-138  0.96
2013 Smarr CB, Bryce PJ, Miller SD. Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases. Critical Reviews in Immunology. 33: 389-414. PMID 24099300 DOI: 10.1615/CritRevImmunol.2013007046  0.96
2013 Mayes DA, Rizvi TA, Titus-Mitchell H, Oberst R, Ciraolo GM, Vorhees CV, Robinson AP, Miller SD, Cancelas JA, Stemmer-Rachamimov AO, Ratner N. Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature. Cell Reports. 4: 1197-212. PMID 24035394 DOI: 10.1016/j.celrep.2013.08.011  0.96
2013 Getts DR, Chastain EM, Terry RL, Miller SD. Virus infection, antiviral immunity, and autoimmunity. Immunological Reviews. 255: 197-209. PMID 23947356 DOI: 10.1111/imr.12091  0.96
2013 Rodgers JM, Robinson AP, Miller SD. Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis. Discovery Medicine. 16: 53-63. PMID 23911232  0.96
2013 Wang S, Tasch J, Kheradmand T, Ulaszek J, Ely S, Zhang X, Hering BJ, Miller SD, Luo X. Transient B-cell depletion combined with apoptotic donor splenocytes induces xeno-specific T- and B-cell tolerance to islet xenografts. Diabetes. 62: 3143-50. PMID 23852699 DOI: 10.2337/db12-1678  0.96
2013 Wan E, Yeap XY, Dehn S, Terry R, Novak M, Zhang S, Iwata S, Han X, Homma S, Drosatos K, Lomasney J, Engman DM, Miller SD, Vaughan DE, Morrow JP, et al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circulation Research. 113: 1004-12. PMID 23836795 DOI: 10.1161/CIRCRESAHA.113.301198  0.96
2013 Lutterotti A, Yousef S, Sputtek A, Stürner KH, Stellmann JP, Breiden P, Reinhardt S, Schulze C, Bester M, Heesen C, Schippling S, Miller SD, Sospedra M, Martin R. Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Science Translational Medicine. 5: 188ra75. PMID 23740901 DOI: 10.1126/scitranslmed.3006168  0.96
2013 Podojil JR, Liu LN, Marshall SA, Chiang MY, Goings GE, Chen L, Langermann S, Miller SD. B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms. Journal of Autoimmunity. 44: 71-81. PMID 23683881 DOI: 10.1016/j.jaut.2013.04.001  0.96
2013 Robinson AP, Caldis MW, Harp CT, Goings GE, Miller SD. High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis. Journal of Autoimmunity. 43: 32-43. PMID 23514872 DOI: 10.1016/j.jaut.2013.02.005  0.96
2013 Podojil JR, Miller SD. Targeting the B7 family of co-stimulatory molecules: successes and challenges. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 27: 1-13. PMID 23329394 DOI: 10.1007/s40259-012-0001-6  0.96
2013 Getts DR, Getts MT, King NJC, Miller SD. Infectious Triggers of T Cell Autoimmunity The Autoimmune Diseases: Fifth Edition. 263-274. DOI: 10.1016/B978-0-12-384929-8.00019-8  0.96
2012 Prasad S, Xu D, Miller SD. Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes. The Review of Diabetic Studies : Rds. 9: 319-27. PMID 23804269 DOI: 10.1900/RDS.2012.9.319  0.96
2012 Rodgers JM, Miller SD. Cytokine control of inflammation and repair in the pathology of multiple sclerosis. The Yale Journal of Biology and Medicine. 85: 447-68. PMID 23239947  0.96
2012 Getts DR, Martin AJ, McCarthy DP, Terry RL, Hunter ZN, Yap WT, Getts MT, Pleiss M, Luo X, King NJ, Shea LD, Miller SD. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nature Biotechnology. 30: 1217-24. PMID 23159881 DOI: 10.1038/nbt.2434  0.96
2012 Ren Z, Wang Y, Duan T, Patel J, Liggett T, Loda E, Brahma S, Goswami R, Grouse C, Byrne R, Stefoski D, Javed A, Miller SD, Balabanov R. Cross-immunoreactivity between bacterial aquaporin-Z and human aquaporin-4: potential relevance to neuromyelitis optica. Journal of Immunology (Baltimore, Md. : 1950). 189: 4602-11. PMID 23008451 DOI: 10.4049/jimmunol.1200486  0.96
2012 McCarthy DP, Richards MH, Miller SD. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease. Methods in Molecular Biology (Clifton, N.J.). 900: 381-401. PMID 22933080 DOI: 10.1007/978-1-60761-720-4_19  0.96
2012 Kheradmand T, Wang S, Bryant J, Tasch JJ, Lerret N, Pothoven KL, Houlihan JL, Miller SD, Zhang ZJ, Luo X. Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance. Journal of Immunology (Baltimore, Md. : 1950). 189: 804-12. PMID 22696445 DOI: 10.4049/jimmunol.1103705  0.96
2012 Prasad S, Kohm AP, McMahon JS, Luo X, Miller SD. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. Journal of Autoimmunity. 39: 347-53. PMID 22647732 DOI: 10.1016/j.jaut.2012.04.005  0.96
2012 Chang RA, Miller SD, Longnecker R. Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function. Scientific Reports. 2: 353. PMID 22616025 DOI: 10.1038/srep00353  0.96
2012 Chastain EM, Miller SD. Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunological Reviews. 245: 227-38. PMID 22168423 DOI: 10.1111/j.1600-065X.2011.01076.x  0.96
2012 Eagar TN, Miller SD. Helper T-cell subsets and control of the inflammatory response Clinical Immunology: Principles and Practice: Fourth Edition. 203-214. DOI: 10.1016/B978-0-7234-3691-1.00014-3  0.96
2011 Fu Y, Frederick TJ, Huff TB, Goings GE, Miller SD, Cheng JX. Paranodal myelin retraction in relapsing experimental autoimmune encephalomyelitis visualized by coherent anti-Stokes Raman scattering microscopy. Journal of Biomedical Optics. 16: 106006. PMID 22029353 DOI: 10.1117/1.3638180  0.96
2011 Smarr CB, Hsu CL, Byrne AJ, Miller SD, Bryce PJ. Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy. Journal of Immunology (Baltimore, Md. : 1950). 187: 5090-8. PMID 21976774 DOI: 10.4049/jimmunol.1100608  0.96
2011 Getts DR, Turley DM, Smith CE, Harp CT, McCarthy D, Feeney EM, Getts MT, Martin AJ, Luo X, Terry RL, King NJ, Miller SD. Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 2405-17. PMID 21821796 DOI: 10.4049/jimmunol.1004175  0.96
2011 Getts DR, Shankar S, Chastain EM, Martin A, Getts MT, Wood K, Miller SD. Current landscape for T-cell targeting in autoimmunity and transplantation. Immunotherapy. 3: 853-70. PMID 21751954 DOI: 10.2217/imt.11.61  0.96
2011 Adipue IA, Wilcox JT, King C, Rice CA, Shaum KM, Suard CM, Brink Et, Miller SD, McMahon EJ. Characterization of a novel and spontaneous mouse model of inflammatory arthritis. Arthritis Research & Therapy. 13: R114. PMID 21749708 DOI: 10.1186/ar3399  0.96
2011 Podojil JR, Padval MV, Miller SD. Combination treatment of mice with CRx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis. Cellular Immunology. 270: 237-50. PMID 21696712 DOI: 10.1016/j.cellimm.2011.05.015  0.96
2011 Banisadr G, Frederick TJ, Freitag C, Ren D, Jung H, Miller SD, Miller RJ. The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter. Neurobiology of Disease. 44: 19-27. PMID 21684336 DOI: 10.1016/j.nbd.2011.05.019  0.96
2011 Duncan DS, Miller SD. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease. Plos One. 6: e18548. PMID 21494618 DOI: 10.1371/journal.pone.0018548  0.96
2011 Kheradmand T, Wang S, Gibly RF, Zhang X, Holland S, Tasch J, Graham JG, Kaufman DB, Miller SD, Shea LD, Luo X. Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials. 32: 4517-24. PMID 21458857 DOI: 10.1016/j.biomaterials.2011.03.009  0.96
2011 Ekong UD, Luo X, Yu M, Wang D, Miller SD, O'Gorman MR. Lymphocyte activation markers may predict the presence of donor specific alloreactivity in pediatric living related liver transplant recipients. Human Immunology. 72: 392-7. PMID 21315129 DOI: 10.1016/j.humimm.2011.02.003  0.96
2011 Richards MH, Getts MT, Podojil JR, Jin YH, Kim BS, Miller SD. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS. Journal of Autoimmunity. 36: 142-54. PMID 21273044 DOI: 10.1016/j.jaut.2010.12.005  0.96
2011 Dogan RN, Long N, Forde E, Dennis K, Kohm AP, Miller SD, Karpus WJ. CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function. Journal of Leukocyte Biology. 89: 93-104. PMID 20940325 DOI: 10.1189/jlb.0810442  0.96
2011 Chastain EM, Duncan DS, Rodgers JM, Miller SD. The role of antigen presenting cells in multiple sclerosis. Biochimica Et Biophysica Acta. 1812: 265-74. PMID 20637861 DOI: 10.1016/j.bbadis.2010.07.008  0.96
2010 Getts DR, Getts MT, McCarthy DP, Chastain EM, Miller SD. Have we overestimated the benefit of human(ized) antibodies? Mabs. 2: 682-94. PMID 20935511 DOI: 10.4161/mabs.2.6.13601  0.96
2010 Traka M, Arasi K, Avila RL, Podojil JR, Christakos A, Miller SD, Soliven B, Popko B. A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain : a Journal of Neurology. 133: 3017-29. PMID 20851998 DOI: 10.1093/brain/awq247  0.96
2010 Martin AJ, McCarthy D, Waltenbaugh C, Goings G, Luo X, Miller SD. Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation. Journal of Immunology (Baltimore, Md. : 1950). 185: 3326-36. PMID 20713889 DOI: 10.4049/jimmunol.1000802  0.96
2010 Pothoven KL, Kheradmand T, Yang Q, Houlihan JL, Zhang H, Degutes M, Miller SD, Luo X. Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 10: 1774-84. PMID 20626386 DOI: 10.1111/j.1600-6143.2010.03199.x  0.96
2010 Gris D, Ye Z, Iocca HA, Wen H, Craven RR, Gris P, Huang M, Schneider M, Miller SD, Ting JP. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. Journal of Immunology (Baltimore, Md. : 1950). 185: 974-81. PMID 20574004 DOI: 10.4049/jimmunol.0904145  0.96
2010 Jin YH, Hou W, Kim SJ, Fuller AC, Kang B, Goings G, Miller SD, Kim BS. Type I interferon signals control Theiler's virus infection site, cellular infiltration and T cell stimulation in the CNS. Journal of Neuroimmunology. 226: 27-37. PMID 20538350 DOI: 10.1016/j.jneuroim.2010.05.028  0.96
2010 Zhang H, Podojil JR, Chang J, Luo X, Miller SD. TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 184: 6629-36. PMID 20483764 DOI: 10.4049/jimmunol.0904044  0.96
2010 Getts MT, Miller SD. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: triggering of autoimmune diseases by infections. Clinical and Experimental Immunology. 160: 15-21. PMID 20415846 DOI: 10.1111/j.1365-2249.2010.04132.x  0.96
2010 Luo X, Herold KC, Miller SD. Immunotherapy of type 1 diabetes: where are we and where should we be going? Immunity. 32: 488-99. PMID 20412759 DOI: 10.1016/j.immuni.2010.04.002  0.96
2010 Getts MT, Richards MH, Miller SD. A critical role for virus-specific CD8(+) CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice. Virology. 402: 102-11. PMID 20381109 DOI: 10.1016/j.virol.2010.02.031  0.96
2010 Rodgers JM, Zhou L, Miller SD. Act1, scene brain: astrocytes play a lead role. Immunity. 32: 302-4. PMID 20346771 DOI: 10.1016/j.immuni.2010.03.009  0.96
2010 Miller SD, Karpus WJ, Davidson TS. Experimental autoimmune encephalomyelitis in the mouse. Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. Unit 15.1. PMID 20143314 DOI: 10.1002/0471142735.im1501s88  0.96
2010 Turley DM, Miller SD. Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis. Results and Problems in Cell Differentiation. 51: 217-35. PMID 19130025 DOI: 10.1007/400_2008_13  0.96
2009 Martin AJ, Zhou L, Miller SD. MicroRNA--managing the TH-17 inflammatory response. Nature Immunology. 10: 1229-31. PMID 19915620 DOI: 10.1038/ni1209-1229  0.96
2009 Podojil JR, Miller SD. Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy. Immunological Reviews. 229: 337-55. PMID 19426232 DOI: 10.1111/j.1600-065X.2009.00773.x  0.96
2009 Olson JK, Miller SD. The innate immune response affects the development of the autoimmune response in Theiler's virus-induced demyelinating disease. Journal of Immunology (Baltimore, Md. : 1950). 182: 5712-22. PMID 19380818 DOI: 10.4049/jimmunol.0801940  0.96
2009 Münz C, Lünemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity? Nature Reviews. Immunology. 9: 246-58. PMID 19319143 DOI: 10.1038/nri2527  0.96
2009 Blink SE, Miller SD. The contribution of gammadelta T cells to the pathogenesis of EAE and MS. Current Molecular Medicine. 9: 15-22. PMID 19199938 DOI: 10.2174/156652409787314516  0.96
2009 Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, Miller RH. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia. 57: 1192-203. PMID 19191336 DOI: 10.1002/glia.20841  0.96
2009 Podojil JR, Miller SD. Cross-linking of CD80 on CD4+ T cells activates a calcium-dependent signaling pathway. Journal of Immunology (Baltimore, Md. : 1950). 182: 766-73. PMID 19124719  0.96
2009 Ercolini AM, Miller SD. The role of infections in autoimmune disease Clinical and Experimental Immunology. 155: 1-15. PMID 19076824 DOI: 10.1111/j.1365-2249.2008.03834.x  0.96
2009 Ekong UD, Miller SD, O'Gorman MR. In vitro assays of allosensitization. Pediatric Transplantation. 13: 25-34. PMID 19017286 DOI: 10.1111/j.1399-3046.2008.01042.x  0.96
2008 Getts MT, Getts DR, Kohm AP, Miller SD. Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis. Therapy (London, England : 2004). 5: 631-640. PMID 20357912 DOI: 10.2217/14750708.5.5.631  0.96
2008 Podojil JR, Turley DM, Miller SD. Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune disease. Advances in Experimental Medicine and Biology. 640: 234-51. PMID 19065796 DOI: 10.1007/978-0-387-09789-3_18  0.96
2008 Greene MT, Ercolini AM, DeGutes M, Miller SD. Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor. Journal of Autoimmunity. 31: 399-407. PMID 19008075 DOI: 10.1016/j.jaut.2008.09.004  0.96
2008 Edlynn ES, Gaylord-Harden NK, Richards MH, Miller SA. African American inner-city youth exposed to violence: coping skills as a moderator for anxiety. The American Journal of Orthopsychiatry. 78: 249-58. PMID 18954188 DOI: 10.1037/a0013948  0.56
2008 Goings GE, Greisman A, James RE, Abram LK, Begolka WS, Miller SD, Szele FG. Hematopoietic cell activation in the subventricular zone after Theiler's virus infection. Journal of Neuroinflammation. 5: 44. PMID 18922161 DOI: 10.1186/1742-2094-5-44  0.96
2008 Schreiner B, Bailey SL, Shin T, Chen L, Miller SD. PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. European Journal of Immunology. 38: 2706-17. PMID 18825752 DOI: 10.1002/eji.200838137  0.96
2008 Zhang H, Podojil JR, Luo X, Miller SD. Intrinsic and induced regulation of the age-associated onset of spontaneous experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 181: 4638-47. PMID 18802066  0.96
2008 Cannon JL, Collins A, Mody PD, Balachandran D, Henriksen KJ, Smith CE, Tong J, Clay BS, Miller SD, Sperling AI. CD43 regulates Th2 differentiation and inflammation. Journal of Immunology (Baltimore, Md. : 1950). 180: 7385-93. PMID 18490738  0.96
2008 Bailey-Bucktrout SL, Caulkins SC, Goings G, Fischer JA, Dzionek A, Miller SD. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 180: 6457-61. PMID 18453561  0.96
2008 Carpentier PA, Getts MT, Miller SD. Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease. Virology. 375: 24-36. PMID 18289626 DOI: 10.1016/j.virol.2008.01.024  0.96
2008 Carpentier PA, Duncan DS, Miller SD. Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain, Behavior, and Immunity. 22: 140-7. PMID 17920811 DOI: 10.1016/j.bbi.2007.08.011  0.96
2008 Carpentier PA, Duncan DS, Miller SD. Pattern recognition receptors in CNS disease Central Nervous System Diseases and Inflammation. 131-152. DOI: 10.1007/978-0-387-73894-9_7  0.96
2008 Bailey SL, Miller SD. CNS dendritic cells in inflammation and disease Central Nervous System Diseases and Inflammation. 263-275. DOI: 10.1007/978-0-387-73894-9_13  0.96
2007 Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nature Reviews. Immunology. 7: 665-77. PMID 17690713 DOI: 10.1038/nri2153  0.96
2007 Getts MT, Kim BS, Miller SD. Differential outcome of tolerance induction in naive versus activated Theiler's virus epitope-specific CD8+ cytotoxic T cells. Journal of Virology. 81: 6584-93. PMID 17428853 DOI: 10.1128/JVI.00008-07  0.96
2007 Turley DM, Miller SD. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 178: 2212-20. PMID 17277126  0.96
2007 Carpentier PA, Williams BR, Miller SD. Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli. Glia. 55: 239-52. PMID 17091495 DOI: 10.1002/glia.20450  0.96
2006 Smith CE, Miller SD. Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities. Journal of Autoimmunity. 27: 218-31. PMID 17289470 DOI: 10.1016/j.jaut.2006.12.002  0.96
2006 Bailey SL, Carpentier PA, McMahon EJ, Begolka WS, Miller SD. Innate and adaptive immune responses of the central nervous system. Critical Reviews in Immunology. 26: 149-88. PMID 16700651 DOI: 10.1207/s15326977ea1103&4_2  0.96
2005 Kohm AP, Turley DM, Miller SD. Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease. International Reviews of Immunology. 24: 361-92. PMID 16318987 DOI: 10.1080/08830180500371207  0.96
2005 Minter LM, Turley DM, Das P, Shin HM, Joshi I, Lawlor RG, Cho OH, Palaga T, Gottipati S, Telfer JC, Kostura L, Fauq AH, Simpson K, Such KA, Miele L, ... ... Miller SD, et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nature Immunology. 6: 680-8. PMID 15991363 DOI: 10.1038/ni1209  0.96
2005 Smith CE, Eagar TN, Strominger JL, Miller SD. Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. 102: 9595-600. PMID 15983366 DOI: 10.1073/pnas.0504131102  0.96
2005 Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia. 49: 360-74. PMID 15538753 DOI: 10.1002/glia.20117  0.96
2004 Eagar TN, Turley DM, Padilla J, Karandikar NJ, Tan L, Bluestone JA, Miller SD. CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance. Journal of Immunology (Baltimore, Md. : 1950). 172: 7442-50. PMID 15187122  0.96
2003 Kohm AP, Carpentier PA, Miller SD. Regulation of experimental autoimmune encephalomyelitis (EAE) by CD4+CD25+ regulatory T cells. Novartis Foundation Symposium. 252: 45-52; discussion 52. PMID 14609211  0.96
2003 Mack CL, Vanderlugt-Castaneda CL, Neville KL, Miller SD. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis. Journal of Neuroimmunology. 144: 68-79. PMID 14597100 DOI: 10.1016/j.jneuroim.2003.08.032  0.96
2003 Howard LM, Neville KL, Haynes LM, Dal Canto MC, Miller SD. CD154 blockade results in transient reduction in Theiler's murine encephalomyelitis virus-induced demyelinating disease. Journal of Virology. 77: 2247-50. PMID 12525660 DOI: 10.1128/JVI.77.3.2247-2250.2003  0.96
2002 Kohm AP, Carpentier PA, Anger HA, Miller SD. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 169: 4712-6. PMID 12391178  0.96
2002 Olson JK, Eagar TN, Miller SD. Functional activation of myelin-specific T cells by virus-induced molecular mimicry. Journal of Immunology (Baltimore, Md. : 1950). 169: 2719-26. PMID 12193746  0.96
2002 Girvin AM, Gordon KB, Welsh CJ, Clipstone NA, Miller SD. Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells. Blood. 99: 3692-701. PMID 11986225 DOI: 10.1182/blood-2001-12-0229  0.96
2002 Eagar TN, Karandikar NJ, Bluestone JA, Miller SD. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. European Journal of Immunology. 32: 972-81. PMID 11920563 DOI: 10.1002/1521-4141(200204)32:4<972::AID-IMMU972>3.0.CO;2-M  0.96
2002 Girvin AM, Dal Canto MC, Miller SD. CD40/CD40L interaction is essential for the induction of EAE in the absence of CD28-mediated co-stimulation. Journal of Autoimmunity. 18: 83-94. PMID 11908941 DOI: 10.1006/jaut.2001.0573  0.96
2002 Neville KL, Padilla J, Miller SD. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS. Journal of Neuroimmunology. 123: 18-29. PMID 11880145 DOI: 10.1016/S0165-5728(01)00479-9  0.96
2002 Howard LM, Ostrovidov S, Smith CE, Dal Canto MC, Miller SD. Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 109: 233-41. PMID 11805135 DOI: 10.1172/JCI14374  0.96
2001 Begolka WS, Haynes LM, Olson JK, Padilla J, Neville KL, Dal Canto M, Palma J, Kim BS, Miller SD. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology. Journal of Neurovirology. 7: 409-20. PMID 11582513 DOI: 10.1080/135502801753170264  0.96
2001 Olson JK, Girvin AM, Miller SD. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. Journal of Virology. 75: 9780-9. PMID 11559811 DOI: 10.1128/JVI.75.20.9780-9789.2001  0.96
2001 Salomon B, Rhee L, Bour-Jordan H, Hsin H, Montag A, Soliven B, Arcella J, Girvin AM, Padilla J, Miller SD, Bluestone JA. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. The Journal of Experimental Medicine. 194: 677-84. PMID 11535635 DOI: 10.1084/jem.194.5.677  0.96
2001 Miller SD, Eagar TN. Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases. Advances in Experimental Medicine and Biology. 490: 99-107. PMID 11505979  0.96
2001 Miller SD, Katz-Levy Y, Neville KL, Vanderlugt CL. Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system. Advances in Virus Research. 56: 199-217. PMID 11450300  0.96
2001 Theien BE, Vanderlugt CL, Eagar TN, Nickerson-Nutter C, Nazareno R, Kuchroo VK, Miller SD. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 107: 995-1006. PMID 11306603 DOI: 10.1172/JCI11717  0.96
2000 Suvannavejh GC, Lee HO, Padilla J, Dal Canto MC, Barrett TA, Miller SD. Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis. Cellular Immunology. 205: 24-33. PMID 11078604 DOI: 10.1006/cimm.2000.1706  0.96
2000 Katz-Levy Y, Neville KL, Padilla J, Rahbe S, Begolka WS, Girvin AM, Olson JK, Vanderlugt CL, Miller SD. Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice. Journal of Immunology (Baltimore, Md. : 1950). 165: 5304-14. PMID 11046065  0.96
2000 Sabelko-Downes KA, Gimenez MT, Suvannavejh GC, Miller SD, Russell JH. Genetic control of pathogenic mechanisms in autoimmune demyelinating disease. Journal of Neuroimmunology. 110: 168-76. PMID 11024547 DOI: 10.1016/S0165-5728(00)00350-7  0.96
2000 Karandikar NJ, Eagar TN, Vanderlugt CL, Bluestone JA, Miller SD. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 109: 173-80. PMID 10996219 DOI: 10.1016/S0165-5728(00)00322-2  0.96
2000 Neville KL, Dal Canto MC, Bluestone JA, Miller SD. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease. Journal of Virology. 74: 8349-57. PMID 10954534 DOI: 10.1128/JVI.74.18.8349-8357.2000  0.96
2000 Suvannavejh GC, Dal Canto MC, Matis LA, Miller SD. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 105: 223-31. PMID 10642601 DOI: 10.1172/JCI8561  0.96
2000 Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 164: 670-8. PMID 10623809  0.96
2000 Girvin AM, Dal Canto MC, Rhee L, Salomon B, Sharpe A, Bluestone JA, Miller SD. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. Journal of Immunology (Baltimore, Md. : 1950). 164: 136-43. PMID 10605004  0.96
1999 Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, Miller SD. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. The Journal of Clinical Investigation. 104: 599-610. PMID 10487774 DOI: 10.1172/JCI7292  0.96
1998 Vanderlugt CL, Begolka WS, Neville KL, Katz-Levy Y, Howard LM, Eagar TN, Bluestone JA, Miller SD. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunological Reviews. 164: 63-72. PMID 9795764 DOI: 10.1111/j.1600-065X.1998.tb01208.x  0.96
1997 Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nature Medicine. 3: 1133-6. PMID 9334726 DOI: 10.1038/nm1097-1133  0.96
1997 Miller SD, Vanderlugt CL, Begolka WS, Pao W, Neville KL, Yauch RL, Kim BS. Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus. Journal of Neurovirology. 3: S62-5. PMID 9179798  0.96
Show low-probability matches.